sulfinpyrazone has been researched along with Cardiac Hypertrophy in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patient presented with acute renal failure requiring hemodialysis." | 5.27 | [Acute interstitial nephritis and kidney failure requiring dialysis after sulfinpyrazone therapy]. ( Kirchmair, H; Prior, C, 1984) |
| "The patient presented with acute renal failure requiring hemodialysis." | 1.27 | [Acute interstitial nephritis and kidney failure requiring dialysis after sulfinpyrazone therapy]. ( Kirchmair, H; Prior, C, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hilliker, KS | 1 |
| Roth, RA | 1 |
| Prior, C | 1 |
| Kirchmair, H | 1 |
2 other studies available for sulfinpyrazone and Cardiac Hypertrophy
| Article | Year |
|---|---|
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogen | 1984 |
[Acute interstitial nephritis and kidney failure requiring dialysis after sulfinpyrazone therapy].
Topics: Acute Kidney Injury; Aged; Cardiomegaly; Humans; Kidney; Male; Nephritis, Interstitial; Renal Dialys | 1984 |